Epidemiology of metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis and associated cardiometabolic factors in adults in China (2013-2023): A systematic review and meta-analysis

Figure 2 Forest plot of the prevalence of metabolic dysfunction-associated steatohepatitis and the annual incidence of metabolic dysfunction-associated steatotic liver disease. A: Forest plot of the prevalence of metabolic dysfunction-associated steatohepatitis; B: Forest plot of the annual incidence of metabolic dysfunction-associated steatotic liver disease. CI: Confidence interval.